These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23031374)

  • 1. Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab.
    Romero-Maté A; Martínez-Sánchez D; Tardío JC; Moreno-Torres A; García-Donoso C; Aguado-Lobo M; Espinosa-Lara P; Borbujo J
    Dermatol Online J; 2012 Sep; 18(9):7. PubMed ID: 23031374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
    Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
    Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.
    Català A; Roé E; Dalmau J; Pomar V; Muñoz C; Yelamos O; Puig L
    Dermatology; 2015; 230(3):204-7. PubMed ID: 25633623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab.
    Gomes KW; Benevides AN; Vieira FJ; Burlamaqui MP; Vieira Mde A; Fontenelle LM
    Rev Bras Reumatol; 2012; 52(3):447-52. PubMed ID: 22641598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab.
    Stephenson SR; Campbell SM; Drew GS; Magro CM
    J Cutan Pathol; 2011 Aug; 38(8):644-8. PubMed ID: 21592182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous leishmaniasis in rheumatoid arthritis].
    Hachicha I; Sellami M; Fourati H; Akrout R; Hdiji N; Baklouti S
    Rev Med Interne; 2009 Jul; 30(7):609-12. PubMed ID: 19285366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid.
    Aguado M; Espinosa P; Romero-Maté A; Tardío JC; Córdoba S; Borbujo J
    Actas Dermosifiliogr; 2013 May; 104(4):334-42. PubMed ID: 23567452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].
    Bouomrani S; Farah A; Ayadi N; Béji M
    Med Mal Infect; 2011 Jun; 41(6):344-5. PubMed ID: 21493026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leishmaniasis in rheumatoid arthritis].
    Pizzorni C; Secchi ME; Cutolo M
    Reumatismo; 2007; 59(3):235-9. PubMed ID: 17898884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
    Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
    Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases.
    Dhaille F; Viseux V; Caudron A; Dadban A; Tribout C; Boumier P; Clabaut A; Lok C
    Dermatology; 2010; 220(3):234-7. PubMed ID: 20185892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More experiences with the Tzanck smear test: cytologic findings in cutaneous granulomatous disorders.
    Durdu M; Baba M; Seçkin D
    J Am Acad Dermatol; 2009 Sep; 61(3):441-50. PubMed ID: 19700014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis.
    Guerin M; Haettich B; Bara C; Artru L; Prophette B; Célérier P; Maillard H
    Rheumatol Int; 2012 Sep; 32(9):2937-40. PubMed ID: 21800115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
    Atzeni F; Sarzi-Puttini P; Dell' Acqua D; de Portu S; Cecchini G; Cruini C; Carrabba M; Meroni PL
    Arthritis Res Ther; 2006; 8(1):R3. PubMed ID: 16356192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.